Clinical Trial: Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)
Study Status: Completed
Recruit Status: RECRUITING
Condition: Soft Tissue Sarcoma
Study Type: INTERVENTIONAL
Official Title: ADI-PEG 20 or Placebo Plus Gemcitabine and Docetaxel in Previously Treated Subjects With Leiomyosarcoma (ARGSARC): A Randomized, Double Blind, Multi-Center Phase 3 Trial
Brief Summary:
To compare the efficacy and safety in subjects with advanced or metastatic LMS previously treated with an anthracycline.
Read more